
    
      -  Women with Federation of Gynecology and Obstetrics (FIGO) Clinical Stage IB2-IVB
           carcinoma of the cervix

        -  Baseline cervical biopsy, blood samples, and FDG-PET/computed tomography (CT) scan

        -  Cetuximab 400 mg/m2 on day 1 followed by cetuximab 250 mg/m2 on days 8 and 15

        -  Repeat cervical biopsy and FDG-PET/CT scan following cetuximab monotherapy

        -  Radiation and weekly cisplatin 40 mg/m2 and cetuximab 250 mg/2 for 6 weeks

        -  Cetuximab 250 mg/m2 weekly for 12 weeks

        -  Repeat cervical biopsy (if tumor present) and FDG-PET/CT scan after completion of
           therapy

        -  Follow for tumor recurrence and survival
    
  